Phathom Pharmaceuticals Inc’s filing revealed that its CFO and CBO Henderson Molly unloaded Company’s shares for reported $43371.0 on Jan 21 ’25. In the deal valued at $6.59 per share,6,583 shares were sold. As a result of this transaction, Henderson Molly now holds 93,546 shares worth roughly $0.52 million.
Then, Nabulsi Azmi sold 7,886 shares, generating $51,957 in total proceeds. Upon selling the shares at $6.59, the Chief Operating Officer now owns 233,390 shares.
Before that, Curran Terrie sold 19,109 shares. Phathom Pharmaceuticals Inc shares valued at $125,884 were divested by the President and Chief Executive at a price of $6.59 per share. As a result of the transaction, Curran Terrie now holds 360,465 shares, worth roughly $2.01 million.
Cantor Fitzgerald initiated its Phathom Pharmaceuticals Inc [PHAT] rating to an Overweight in a research note published on February 14, 2025; the price target was $23. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Needham also remained covering PHAT and reiterated its “Buy” recommendation on January 05, 2024. H.C. Wainwright started covering the stock on August 09, 2023. It rated PHAT as “a Buy”.
Price Performance Review of PHAT
On Tuesday, Phathom Pharmaceuticals Inc [NASDAQ:PHAT] saw its stock jump 4.49% to $5.58. Over the last five days, the stock has lost -2.45%. Phathom Pharmaceuticals Inc shares have fallen nearly -31.28% since the year began. Nevertheless, the stocks have fallen -46.70% over the past one year. While a 52-week high of $19.71 was reached on 01/02/25, a 52-week low of $5.21 was recorded on 02/11/25. SMA at 50 days reached $6.80, while 200 days put it at $11.47.
Levels Of Support And Resistance For PHAT Stock
The 24-hour chart illustrates a support level at 5.36, which if violated will result in even more drops to 5.14. On the upside, there is a resistance level at 5.75. A further resistance level may holdings at 5.92. The Relative Strength Index (RSI) on the 14-day chart is 40.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.88%. Stochastics %K at 26.91% indicates the stock is a holding.
